A powerful new study to predict and prevent anti-MAG neuropathy

We are proud to announce that with the help from generous donors, the Foundation for Peripheral Neuropathy is funding an important new research study. We are investing $525,000 over the next three years to support this work. This project brings hope to people living with IgM peripheral neuropathy (IgM-PNP), also known as anti-MAG neuropathy. It is a rare nerve disease that […]

Read More… from A powerful new study to predict and prevent anti-MAG neuropathy

A Call to Action for Peripheral Neuropathy Research: NIH Collaboration, Funding Gaps, and the Future of PN Treatment

Peripheral Neuropathy Affects Millions Worldwide Peripheral neuropathy (PN) affects an estimated 30 million Americans and approximately 130 million people worldwide. There are dozens of causes, but metabolic disease — including obesity, pre-diabetes, and diabetes — is by far the leading driver of PN. Metabolic Disease as the Leading Cause of Peripheral Neuropathy Metabolic dysfunction plays […]

Read More… from A Call to Action for Peripheral Neuropathy Research: NIH Collaboration, Funding Gaps, and the Future of PN Treatment

Charitable tax deductions may rise this year

Recent tax law changes will increase deductions for charitable contributions for some donors this year. Here is a high-level summary Starting this year, single filers who don’t itemize their contributions (about 90% of taxpayers) can claim a deduction for up to $1,000 in charitable contributions and joint filers can claim up to $2,000 on their tax returns. This is an increase from the $300/$600 amounts last year. This is a […]

Read More… from Charitable tax deductions may rise this year

The Foundation for Peripheral Neuropathy Received Transformational Gift

We are honored to share that on October 20, 2025, the Foundation for Peripheral Neuropathy (FPN) received the incredible gift of a substantial sum from our longtime supporter and friend, Lynne Warner. This generous donation, given in her memory, will have a lasting impact and bring hope to the peripheral neuropathy community.  About Lynne Warner  […]

Read More… from The Foundation for Peripheral Neuropathy Received Transformational Gift

New Board Member, George Montague: Helping People Live Healthier Lives

Meet George Montague, Treasurer, Board of Directors at the Foundation for Peripheral Neuropathy We’re excited to welcome George Montague to our board of directors. Montague has worked in the healthcare field for many years and knows a lot about how to run companies. Now, he wants to use that knowledge to help people living with […]

Read More… from New Board Member, George Montague: Helping People Live Healthier Lives

New Board Member Jennie Starr: A Builder with a Big Heart

We’re pleased to announce our newest board member, Jennie Starr. Starr started her career as a lawyer, then worked for both tech and biotech companies. She also ran a nonprofit while raising her children. Now she’s bringing all of that experience to help support our mission.  About Jennie Starr  Starr has always liked building new […]

Read More… from New Board Member Jennie Starr: A Builder with a Big Heart

Vertex Joins Forces with the Foundation for Peripheral Neuropathy as 2025 Premier Impact Partner

The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Vertex Pharmaceuticals, as an esteemed 2025 Premier Impact Sponsor. This collaboration marks a significant milestone in FPN’s mission to advance patient education for individuals affected by peripheral neuropathy (PN).  Collaboration for Impact At FPN, our commitment to improving the lives of those living […]

Read More… from Vertex Joins Forces with the Foundation for Peripheral Neuropathy as 2025 Premier Impact Partner

FPN welcomes The Ohio State University as a new site for the IMAGiNe Study

The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]

Read More… from FPN welcomes The Ohio State University as a new site for the IMAGiNe Study